Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

I’ve introduced legislation in Florida to expand options for obesity treatment, including public health insurance coverage. | ...

As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters are reflecting on a week of impactful advocacy and awareness. The year's theme, "Commit to Care," inspired widespread ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Republicans trying to find billions of Medicaid dollars to pay for tax cuts now say that any reduction in Medicaid spending ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...